Physician

Robert S. Haber, M.D.

According to 2025 Medicare claims, Robert Haber, M.D. (NPI: 1346233160) practices dermatology in the Cleveland, OH market, with the plurality of this provider's patient population coming from Cuyahoga, OH. This provider's primary affiliated billing organization is HABER DERMATOLOGY INC. (NPI: 1689859951; TIN: 02-0641311) and primary practice location at 44122-9998.

Haber's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 369 traditional Medicare patients, billed 5,338 HCPCS/CPT codes, and received $451,022 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 939 prescription claims across 233 beneficiaries totaling $17,566 in drug costs, led by Minoxidil (Minoxidil). Open Payments data shows 45 records totaling $1,020. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $34,524 to $451,022. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $20,355 and ending at $17,566. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$226K$451K2015 Medicare payment: $34,524 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $8,778 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $13,143 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $41,302 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $64,054 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $62,993 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $77,198 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $340,380 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $441,845 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $451,022 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015165993$34,524
201674284$8,778
201773305$13,143
2018118899$41,302
20191831,369$64,054
20202001,569$62,993
20212381,780$77,198
20222933,916$340,380
20233214,732$441,845
20243695,338$451,022

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$27K$54K2015 Drug cost: $20,355 (USD; Tot_Drug_Cst)2016 Drug cost: $17,126 (USD; Tot_Drug_Cst)2017 Drug cost: $10,531 (USD; Tot_Drug_Cst)2018 Drug cost: $8,145 (USD; Tot_Drug_Cst)2019 Drug cost: $24,695 (USD; Tot_Drug_Cst)2020 Drug cost: $15,952 (USD; Tot_Drug_Cst)2021 Drug cost: $24,766 (USD; Tot_Drug_Cst)2022 Drug cost: $23,528 (USD; Tot_Drug_Cst)2023 Drug cost: $53,959 (USD; Tot_Drug_Cst)2024 Drug cost: $17,566 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201575178$20,355
201659141$17,126
201748125$10,531
201876180$8,145
2019120408$24,695
2020143489$15,952
2021194721$24,766
2022199701$23,528
2023194743$53,959
2024233939$17,566

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths114159$68
11102Biopsy of related skin growth, first growth6583$59
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more140267$58
99212Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more231381$34
17000Destruction of precancer skin growth, 1 growth94168$33

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
MinoxidilMinoxidil44833,038$2,611
Triamcinolone AcetonideTriamcinolone Acetonide883,218$2,034
FinasterideFinasteride14612,058$1,589
DesonideDesonide12333$1,480
DutasterideDutasteride281,800$1,146

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.45$1,020Lilly USA, LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Robert S. Haber, M.D.?

Tedicare shows public-source Medicare data for Robert S. Haber, M.D. (NPI 1346233160), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Robert S. Haber, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Robert S. Haber, M.D.?

Robert S. Haber, M.D. is linked to HABER DERMATOLOGY INC. (billing NPI 1689859951) in the available physician profile data.

Does Robert S. Haber, M.D. have Open Payments data?

Robert S. Haber, M.D. has 45 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.